Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac IPO & Placement Research, China biotech

Tencent/Netease: Breakthrough in November Batch of Game Approval

China Internet Weekly (21Nov2022): NetEase, Blizzard, Tencent, Meituan, Tencent Music, JD Logistics

Meituan (3690 HK): 3Q22, Growth Higher, Loss Close to Zero, 90% Upside

Tencent/Netease: Increasing Pressure with Zero Approval in August Batch & Thoughts on Trading

Tencent/Netease: Under Pressure with No Game Approval in July

Tencent/Netease: Smell of Common Prosperity in June Game Approval

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Quantitative Analysis

<ul>
<li>China just announced game approval for September batch. More games were approved in September compared to July, June and August.</li>
<li>Pace of China game approval continued to pick up albeit at a much slower pace than pre-tightening.</li>
<li>Tencent continue to score zero and Netease managed to get one game approved in 14 months. </li>
</ul>


China just announced game approval for September batch. More games were approved in September compared to July, June and August.
Pace of China game approval continued to pick up albeit at a much slower pace than pre-tightening.
Tencent continue to score zero and Netease managed to get one game approved in 14 months. 


Tencent/Netease: September Batch of Game Approval & Thoughts on Trading